Pneumonia Viral
📧 Sign up to get email alerts when something new happens for Pneumonia Viral.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies
Clinical trial update on a next-generation non-invasive passive detection technology for COVID-19/SARS-CoV-2, with the study currently activ…
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Cromolyn Sodium for Treatment of COVID-19 Pneumonia [Phase 3]
A Phase 3 clinical trial evaluating cromolyn sodium for COVID-19 pneumonia has been terminated.
-
CLINICAL_TRIALS trial_result · 2023-08-18Clinical Trial Update: Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects [Phase 3]
A Phase 3 randomized, double-blind, placebo-controlled trial evaluating fostamatinib for COVID-19 has completed enrollment and study status.
-
CLINICAL_TRIALS withdrawal · 2023-03-31Clinical Trial Update: Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium [Phase 4]
A Phase 4 clinical trial evaluating valproate alone or with quetiapine for severe COVID-19 pneumonia with agitated delirium has been withdra…
-
CLINICAL_TRIALS trial_result · 2023-03-01Clinical Trial Update: DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia [Phase 3]
Phase 3 clinical trial update evaluating early dexamethasone administration in hospitalized COVID-19 pneumonia patients. Current status is u…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-01-26Clinical Trial Update: Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating nitric oxide therapy in COVID-19 patients requiring oxygen.
-
CLINICAL_TRIALS trial_result · 2022-11-15Clinical Trial Update: Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in Thailand [Phase 1, Phase 2]
Phase 1/2 trial results assessing safety and immunogenicity of the NDV-HXP-S vaccine in Thailand have been completed.
-
CLINICAL_TRIALS trial_result · 2022-07-20Clinical Trial Update: Colchicine Counteracting Inflammation in COVID-19 Pneumonia [Phase 2]
Phase 2 trial investigating colchicine to counteract inflammation in COVID-19 pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-24Clinical Trial Update: Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia [Phase 3]
Phase 3 trial of IV ravulizumab in COVID-19 severe pneumonia was terminated; results posted but no ongoing study.
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19) [Phase 2]
Phase 2 randomized open-label trial evaluating inhaled ciclesonide for patients with COVID-19 (HALT COVID-19).
-
CLINICAL_TRIALS trial_result · 2022-01-31Clinical Trial Update: Effect of Respiratory Exerciser on Pulmonary Functions of COVID-19 Patients
A completed clinical trial evaluating the effect of a respiratory exerciser on pulmonary function in COVID-19 patients; results posted in 20…
-
CLINICAL_TRIALS trial_result · 2021-12-15Clinical Trial Update: Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial) [Phase 2, Phase 3]
Clinical trial comparing hydroxychloroquine plus azithromycin versus hydroxychloroquine alone for COVID-19 pneumonia has been terminated.
-
CLINICAL_TRIALS trial_result · 2021-08-23Clinical Trial Update: Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating allogenic pooled olfactory mucosa-derived mesenchymal stem cells for treatment of COVID-19 associated …
-
CLINICAL_TRIALS trial_result · 2021-07-22Clinical Trial Update: Nitazoxanide Therapy for Patients With COVID-19 Pneumonia [Phase 2]
Phase 2 clinical trial evaluating nitazoxanide therapy for patients with COVID-19 pneumonia has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-06Clinical Trial Update: Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection [Phase 3]
Phase 3 trial evaluating steroids and unfractionated heparin in critically ill COVID-19 pneumonia patients.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Spironolactone and Dexamethasone in Patients Hospitalized With COVID-19 [Phase 3]
Phase 3 clinical trial evaluating spironolactone and dexamethasone in hospitalized COVID-19 patients.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19 [Phase 2, Phase 3]
A clinical trial update on the effectiveness of off-label mefloquine for treating viral pneumonia and respiratory failure in COVID-19 patien…
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II) [Phase 3]
A Phase 3 trial evaluating safety and efficacy of hydroxychloroquine plus azithromycin for coronavirus infections, completed.
-
CLINICAL_TRIALS trial_result · 2020-08-07Clinical Trial Update: COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III [Phase 3]
Phase 3 trial assessing dexamethasone for COVID-19-associated ARDS was terminated. The study evaluated dexamethasone treatment in patients w…
-
CLINICAL_TRIALS trial_result · 2020-04-29Clinical Trial Update: Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19 [Phase 2]
Phase 2 trial evaluating enhanced platelet inhibition in critically ill COVID-19 patients has completed.
-
CLINICAL_TRIALS trial_result · 2020-04-28Clinical Trial Update: Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora [Phase 2]
Phase 2 clinical trial investigating oxygen-ozone as adjuvant treatment for early control of COVID-19 progression and modulation of gut micr…